{"id":324521,"date":"2022-10-09T13:39:54","date_gmt":"2022-10-09T11:39:54","guid":{"rendered":"https:\/\/medizinonline.com\/el-tratamiento-de-la-llc-r-r-directrices-estudios-y-casos-clinicos\/"},"modified":"2022-10-09T13:39:54","modified_gmt":"2022-10-09T11:39:54","slug":"el-tratamiento-de-la-llc-r-r-directrices-estudios-y-casos-clinicos","status":"publish","type":"post","link":"https:\/\/medizinonline.com\/es\/el-tratamiento-de-la-llc-r-r-directrices-estudios-y-casos-clinicos\/","title":{"rendered":"El tratamiento de la LLC R\/R: directrices, estudios y casos cl\u00ednicos"},"content":{"rendered":"<p><strong>Mediante el desarrollo de nuevas sustancias dirigidas, las quimioterapias cl\u00e1sicas pueden sustituirse por enfoques m\u00e1s tolerables<\/strong><strong><br \/>\n  <sup>1<\/sup><br \/>\n<\/strong>.&nbsp;<strong>En este webcast, el doctor Marc Heizmann, m\u00e9dico jefe de hematolog\u00eda y medicina transfusional del Hospital Cantonal de Aarau, habla de las directrices de tratamiento de la LLC R\/R, presenta estudios sobre terapia dirigida y expone dos casos cl\u00ednicos.&nbsp;<\/strong><\/p>\n<p> <!--more--> <\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p><img fetchpriority=\"high\" decoding=\"async\" class=\" size-full wp-image-19558\" alt=\"\" src=\"https:\/\/medizinonline.com\/wp-content\/uploads\/2022\/10\/bildschirmfoto_2022-10-10_um_10.04.00_0.png\" style=\"height:350px; width:1100px\" width=\"1100\" height=\"350\" srcset=\"https:\/\/medizinonline.com\/wp-content\/uploads\/2022\/10\/bildschirmfoto_2022-10-10_um_10.04.00_0.png 1100w, https:\/\/medizinonline.com\/wp-content\/uploads\/2022\/10\/bildschirmfoto_2022-10-10_um_10.04.00_0-800x255.png 800w, https:\/\/medizinonline.com\/wp-content\/uploads\/2022\/10\/bildschirmfoto_2022-10-10_um_10.04.00_0-120x38.png 120w, https:\/\/medizinonline.com\/wp-content\/uploads\/2022\/10\/bildschirmfoto_2022-10-10_um_10.04.00_0-90x29.png 90w, https:\/\/medizinonline.com\/wp-content\/uploads\/2022\/10\/bildschirmfoto_2022-10-10_um_10.04.00_0-320x102.png 320w, https:\/\/medizinonline.com\/wp-content\/uploads\/2022\/10\/bildschirmfoto_2022-10-10_um_10.04.00_0-560x178.png 560w\" sizes=\"(max-width: 1100px) 100vw, 1100px\" \/><\/p>\n<p><iframe frameborder=\"0\" height=\"1200\" data-src=\"https:\/\/player.vimeo.com\/video\/758630881?h=f182288213&amp;badge=0&amp;autopause=0&amp;player_id=0&amp;app_id=58479\" title=\"Heizmann_DE_neu_20220928.mp4\" width=\"1920\" src=\"data:image\/svg+xml;base64,PHN2ZyB3aWR0aD0iMSIgaGVpZ2h0PSIxIiB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciPjwvc3ZnPg==\" class=\"lazyload\" data-load-mode=\"1\"><\/iframe><\/p>\n<p>&nbsp;<\/p>\n<p><strong>Dr. sc. nat. Katja Becker<\/strong><\/p>\n<p>Este art\u00edculo ha sido elaborado con el apoyo financiero de AbbVie AG, Alte Steinhauserstrasse 14, Cham.<\/p>\n<p>CH-VNCCLL-220057 08\/2022<\/p>\n<p><a href=\"https:\/\/assets.medizinonline.com\/sites\/default\/files\/20210318_kfi_venclyxto_v6_de_mar_2020_final_promomats_0.pdf\" target=\"_blank\" rel=\"noopener\">Breve informaci\u00f3n t\u00e9cnica de Venclyxto&nbsp;<\/a><\/p>\n<p>&nbsp;<\/p>\n<p><strong>Literatura<\/strong><\/p>\n<div><span style=\"font-size:9px\">1 Bewarder et al. Opciones de tratamiento actuales en la LLC. C\u00e1nceres (Basilea). 2021 mayo 19;13(10):2468.<\/span><\/div>\n<p>&nbsp;<\/p>\n<p>Las referencias pueden ser solicitadas por los profesionales a&nbsp;<a href=\"mailto:medinfo.ch@abbvie.com\">medinfo.ch@abbvie.com<\/a>&nbsp;.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Mediante el desarrollo de nuevas sustancias dirigidas, las quimioterapias cl\u00e1sicas pueden sustituirse por enfoques m\u00e1s tolerables 1 .&nbsp;En este webcast, el doctor Marc Heizmann, m\u00e9dico jefe de hematolog\u00eda y medicina&hellip;<\/p>\n","protected":false},"author":14,"featured_media":124100,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"pmpro_default_level":"","cat_1_feature_home_top":false,"cat_2_editor_pick":false,"csco_eyebrow_text":"Leucemia linfoc\u00edtica cr\u00f3nica recidivante\/refractaria","footnotes":""},"category":[11493,11487,11475,11321,11336,11552],"tags":[],"powerkit_post_featured":[],"class_list":["post-324521","post","type-post","status-publish","format-standard","has-post-thumbnail","category-casos","category-entrevistas","category-estudios","category-hematologia","category-oncologia","category-rx-es","pmpro-has-access"],"acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-07-13 01:00:18","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"wpml_current_locale":"es_ES","wpml_translations":[],"_links":{"self":[{"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/posts\/324521","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/users\/14"}],"replies":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/comments?post=324521"}],"version-history":[{"count":0,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/posts\/324521\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/media\/124100"}],"wp:attachment":[{"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/media?parent=324521"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/category?post=324521"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/tags?post=324521"},{"taxonomy":"powerkit_post_featured","embeddable":true,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/powerkit_post_featured?post=324521"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}